Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 Diabetes

Name: Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 Diabetes
License: Public Domain

RWTH Aachen University

ClinicalTrials.gov · Datasets · License: Public Domain

diabetes mellitus type 2 (t2dm)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 234599
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.